SUCRALFATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Sucralfate, and what generic alternatives are available?
Sucralfate is a drug marketed by Amneal, Mylan, Pd Partners, Vistapharm, Amneal Pharms, Nostrum Labs Inc, Teva, and Zydus Lifesciences. and is included in eight NDAs.
The generic ingredient in SUCRALFATE is sucralfate. There are fourteen drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the sucralfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sucralfate
A generic version of SUCRALFATE was approved as sucralfate by TEVA on March 29th, 1996.
Summary for SUCRALFATE
US Patents: | 0 |
Applicants: | 8 |
NDAs: | 8 |
Finished Product Suppliers / Packagers: | 33 |
Clinical Trials: | 24 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for SUCRALFATE |
Drug Sales Revenues: | Drug sales revenues for SUCRALFATE |
What excipients (inactive ingredients) are in SUCRALFATE? | SUCRALFATE excipients list |
DailyMed Link: | SUCRALFATE at DailyMed |
Recent Clinical Trials for SUCRALFATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Cheng-Kung University Hospital | Phase 1 |
Memorial Sloan Kettering Cancer Center | Phase 2 |
Bhupesh Parashar, MD | Phase 2 |
Pharmacology for SUCRALFATE
Drug Class | Aluminum Complex |
Medical Subject Heading (MeSH) Categories for SUCRALFATE
Anatomical Therapeutic Chemical (ATC) Classes for SUCRALFATE
US Patents and Regulatory Information for SUCRALFATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amneal | SUCRALFATE | sucralfate | SUSPENSION;ORAL | 209356-001 | Dec 2, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Teva | SUCRALFATE | sucralfate | TABLET;ORAL | 070848-001 | Mar 29, 1996 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Vistapharm | SUCRALFATE | sucralfate | SUSPENSION;ORAL | 211884-001 | Mar 15, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |